Published in J Clin Cell Immunol on April 01, 2015
Matrix Metalloproteinase-9 Production by Immortalized Human Chondrocyte Lines. J Clin Cell Immunol (2016) 0.75
Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma. Sci Rep (2017) 0.75
Phosphorylation of STAT proteins by recombinant human IL-6 in immortalized human chondrocyte cell lines, T/C28a2 and C28/I2. J Inflamm Res (2017) 0.75
The JAK-STAT signaling pathway: input and output integration. J Immunol (2007) 4.92
The JAK-STAT pathway at twenty. Immunity (2012) 4.41
Serine phosphorylation of STATs. Oncogene (2000) 4.21
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86
Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev (2002) 2.69
Autoimmune inflammation from the Th17 perspective. Autoimmun Rev (2006) 2.04
The transcription factor STAT3 is required for T helper 2 cell development. Immunity (2011) 2.03
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Int Immunopharmacol (2005) 1.92
STAT1 as a key modulator of cell death. Cell Signal (2006) 1.85
Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem (2010) 1.76
Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann Rheum Dis (2003) 1.64
Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol (2007) 1.59
A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage (2008) 1.55
IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Mol Cell Biochem (2006) 1.54
The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res (2010) 1.48
gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48
The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol (2009) 1.47
Angiogenesis in rheumatoid arthritis. Histol Histopathol (2006) 1.39
Signaling by STATs. Arthritis Res Ther (2004) 1.35
Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum (2003) 1.35
Retracted Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J Biol Chem (2002) 1.33
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Clin Cancer Res (1999) 1.32
STAT1 and STAT3 in tumorigenesis: A matter of balance. JAKSTAT (2012) 1.27
The Jak-STAT pathway in rheumatoid arthritis. J Rheumatol (2005) 1.26
Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem (2012) 1.25
GP130 cytokines and bone remodelling in health and disease. BMB Rep (2010) 1.23
IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol (2010) 1.13
Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes. Biotechnol Bioeng (2006) 1.12
Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res (2003) 1.08
Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.04
Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys (2000) 1.04
Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways. Arch Pharm Res (2011) 1.02
Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins. Immunology (2012) 1.01
The biochemistry of hematopoietic stem cell development. Biochim Biophys Acta (2012) 1.01
IL-1beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NFkappaB signaling pathways. Cytokine (2004) 1.00
STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest. Cell Cycle (2010) 0.99
Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis. J Biol Chem (2002) 0.97
Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin Chim Acta (2006) 0.95
Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes. Mediators Inflamm (2005) 0.95
Intracellular Signaling Pathways in Rheumatoid Arthritis. J Clin Cell Immunol (2013) 0.95
The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle (2005) 0.93
Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. PLoS One (2011) 0.91
The type I IFN system in rheumatoid arthritis. Autoimmunity (2010) 0.90
Monosodium Urate and Tumor Necrosis Factor-α Increase Apoptosis in Human Chondrocyte Cultures. Rheumatology (Sunnyvale) (2012) 0.88
IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes. Cell Biol Int (2012) 0.87
Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation. J Immunol (2008) 0.85
Small molecular weight inhibitors of stress-activated and mitogen-activated protein kinases. Mini Rev Med Chem (2006) 0.84
Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes. Cell Signal (2008) 0.84